Literature DB >> 14561628

Early characteristics of Sturge-Weber syndrome shown by perfusion MR imaging and proton MR spectroscopic imaging.

Doris D M Lin1, Peter B Barker, Michael A Kraut, Anne Comi.   

Abstract

We report the case of a 9-month-old boy with Sturge-Weber syndrome and new onset of seizure. Perfusion MR imaging showed early changes compatible with impaired venous drainage in the affected hemisphere, whereas proton MR spectroscopic imaging revealed a focal parietal area of elevated choline without significant alteration of N-acetylaspartate levels. The perfusion and subtle metabolic abnormalities are comparable with the extent of the overlying leptomeningeal enhancement, illustrating the early pathophysiological manifestation of this disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14561628      PMCID: PMC7976303     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  13 in total

1.  Scan time reduction in proton magnetic resonance spectroscopic imaging of the human brain.

Authors:  Xavier Golay; Joseph Gillen; Peter C M van Zijl; Peter B Barker
Journal:  Magn Reson Med       Date:  2002-02       Impact factor: 4.668

2.  Early single photon emission computed tomography in Sturge-Weber syndrome.

Authors:  F Pinton; C Chiron; O Enjolras; J Motte; A Syrota; O Dulac
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-11       Impact factor: 10.154

3.  Graded reduction of cerebral blood flow in rat as detected by the nuclear magnetic resonance relaxation time T2: a theoretical and experimental approach.

Authors:  O H Gröhn; M I Kettunen; M Penttonen; J M Oja; P C van Zijl; R A Kauppinen
Journal:  J Cereb Blood Flow Metab       Date:  2000-02       Impact factor: 6.200

4.  Regional cerebral blood flow and metabolism in Sturge-Weber disease.

Authors:  D B Duncan; K Herholz; U Pietrzyk; W D Heiss
Journal:  Clin Nucl Med       Date:  1995-06       Impact factor: 7.794

5.  Noninvasive detection of cerebral hypoperfusion and reversible ischemia from reductions in the magnetic resonance imaging relaxation time, T2.

Authors:  O H Gröhn; J A Lukkarinen; J M Oja; P C van Zijl; J A Ulatowski; R J Traystman; R A Kauppinen
Journal:  J Cereb Blood Flow Metab       Date:  1998-08       Impact factor: 6.200

6.  Proton magnetic resonance spectroscopy in children with Sturge-Weber syndrome.

Authors:  G J Moore; T L Slovis; H T Chugani
Journal:  J Child Neurol       Date:  1998-07       Impact factor: 1.987

7.  Proton MR spectroscopy in patients with seizure disorders.

Authors:  S N Breiter; S Arroyo; V P Mathews; R P Lesser; R N Bryan; P B Barker
Journal:  AJNR Am J Neuroradiol       Date:  1994-02       Impact factor: 3.825

8.  Central nervous system structure and function in Sturge-Weber syndrome: evidence of neurologic and radiologic progression.

Authors:  B L Maria; J A Neufeld; L C Rosainz; W E Drane; R G Quisling; K Ben-David; L M Hamed
Journal:  J Child Neurol       Date:  1998-12       Impact factor: 1.987

9.  Technetium-99m-HMPAO SPECT in Sturge-Weber syndrome.

Authors:  Z Bar-Sever; L P Connolly; P D Barnes; S T Treves
Journal:  J Nucl Med       Date:  1996-01       Impact factor: 10.057

10.  Multisection proton MR spectroscopic imaging of the brain.

Authors:  J H Duyn; J Gillen; G Sobering; P C van Zijl; C T Moonen
Journal:  Radiology       Date:  1993-07       Impact factor: 11.105

View more
  9 in total

1.  Magnetic resonance spectroscopic imaging detects abnormalities in normal-appearing frontal lobe of patients with Sturge-Weber syndrome.

Authors:  Carlos E A Batista; Harry T Chugani; Jiani Hu; E Mark Haacke; Michael E Behen; Emily J Helder; Csaba Juhász
Journal:  J Neuroimaging       Date:  2008-07       Impact factor: 2.486

Review 2.  Presentation, diagnosis, pathophysiology, and treatment of the neurological features of Sturge-Weber syndrome.

Authors:  Anne M Comi
Journal:  Neurologist       Date:  2011-07       Impact factor: 1.398

3.  [Sturge-Weber syndrome. Early manifestation and visualization of disease course].

Authors:  E Stranzinger; T A G M Huisman
Journal:  Radiologe       Date:  2007-12       Impact factor: 0.635

Review 4.  Sturge-Weber syndrome.

Authors:  C Di Rocco; G Tamburrini
Journal:  Childs Nerv Syst       Date:  2006-07-06       Impact factor: 1.475

5.  Stimulant use in patients with sturge-weber syndrome: safety and efficacy.

Authors:  Eboni I Lance; Kira E Lanier; T Andrew Zabel; Anne M Comi
Journal:  Pediatr Neurol       Date:  2013-11-21       Impact factor: 3.372

6.  Clinical correlates of white matter blood flow perfusion changes in Sturge-Weber syndrome: a dynamic MR perfusion-weighted imaging study.

Authors:  Y Miao; C Juhász; J Wu; B Tarabishy; Z Lang; M E Behen; Z Kou; Y Ye; H T Chugani; J Hu
Journal:  AJNR Am J Neuroradiol       Date:  2011-06-30       Impact factor: 3.825

7.  Osseous intramedullary signal alteration and enhancement in Sturge-Weber syndrome: an early diagnostic clue.

Authors:  Matthew T Whitehead; Gilbert Vezina
Journal:  Neuroradiology       Date:  2015-01-16       Impact factor: 2.804

8.  Hemodynamic effects of developmental venous anomalies with and without cavernous malformations.

Authors:  A Sharma; G J Zipfel; C Hildebolt; C P Derdeyn
Journal:  AJNR Am J Neuroradiol       Date:  2013-04-18       Impact factor: 3.825

9.  Aspirin use in Sturge-Weber syndrome: side effects and clinical outcomes.

Authors:  Eboni I Lance; Aditya K Sreenivasan; T Andrew Zabel; Eric H Kossoff; Anne M Comi
Journal:  J Child Neurol       Date:  2012-10-30       Impact factor: 1.987

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.